We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+6.33%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$37.1B
AUM Growth
+$3.97B
(+12%)
Cap. Flow
+$592M
Cap. Flow
% of AUM
1.59%
Top 10 Holdings %
Top 10 Hldgs %
8.58%
Holding
2,714
New
178
Increased
1,030
Reduced
953
Closed
205
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$143M |
| 2 |
WNR
Western Refining Inc
WNR
|
+$142M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$137M |
| 4 |
BHI
Baker Hughes
BHI
|
+$135M |
| 5 |
POM
PEPCO HOLDINGS, INC.
POM
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$215M |
| 2 |
LSI
LSI CORPORATION
LSI
|
+$185M |
| 3 |
Omnicom Group
OMC
|
+$165M |
| 4 |
BRE
BRE PROPERTIES INC CL A
BRE
|
+$95M |
| 5 |
JOSB
JOS A BANK CLOTHIERS INC
JOSB
|
+$83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.43% |
| 2 | Technology | 12.54% |
| 3 | Financials | 10.16% |
| 4 | Energy | 9.99% |
| 5 | Industrials | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPRX
1801
DELISTED
Catalyst Pharmaceutical
CPRX
| $608K | ﹤0.01% |
240,282
+39,000
| +19% | +$83.3K |
|
1802
Martin Marietta Materials
MLM
$33B
| $607K | ﹤0.01% |
+4,600
| New | +$578K |
|
1803
PDF Solutions
PDFS
$2.07B
| $607K | ﹤0.01% |
28,600
-7,800
| -21% | -$149K |
|
|
MNI
1804
DELISTED
The McClatchy Company Class A Common Stock
MNI
| $602K | ﹤0.01% |
10,849
+6,900
| +175% | +$387K |
|
|
CPHD
1805
DELISTED
Cepheid Inc
CPHD
| $602K | ﹤0.01% |
12,565
-100
| -0.8% | -$4.54K |
|
|
WPZ
1806
DELISTED
WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT
WPZ
| $602K | ﹤0.01% |
11,762
| – | – |
|
1807
Marten Transport
MRTN
$1.22B
| $600K | ﹤0.01% |
67,115
+40,250
| +150% | +$367K |
|
1808
Lee Enterprises
LEE
$182M
| $598K | ﹤0.01% |
13,433
| – | – |
|
|
WES
1809
DELISTED
Western Gas Partners Lp
WES
| $595K | ﹤0.01% |
7,781
| – | – |
|
1810
UFP Industries
UFPI
$5.19B
| $593K | ﹤0.01% |
36,882
+1,500
| +4% | +$25.3K |
|
|
NPF
1811
DELISTED
NUVEEN PREMIER MUNI INCOME FD
NPF
| $593K | ﹤0.01% |
43,491
+4,192
| +11% | +$56.5K |
|
1812
Kemper
KMPR
$1.68B
| $588K | ﹤0.01% |
15,946
-3,700
| -19% | -$137K |
|
1813
Caterpillar
CAT
$387B
| $587K | ﹤0.01% |
5,400
-11,700
| -68% | -$1.23M |
|
1814
Tennant Co
TNC
$1.26B
| $587K | ﹤0.01% |
7,697
+1,200
| +18% | +$78.2K |
|
1815
Flowers Foods
FLO
$1.57B
| $585K | ﹤0.01% |
27,751
+600
| +2% | +$12.4K |
|
|
HILL
1816
DELISTED
DOT HILL SYSTEMS CORP
HILL
| $581K | ﹤0.01% |
123,600
| – | – |
|
|
MTSC
1817
DELISTED
MTS Systems Corp
MTSC
| $580K | ﹤0.01% |
8,553
-1,100
| -11% | -$73.4K |
|
|
RPTP
1818
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $580K | ﹤0.01% |
50,191
-33,700
| -40% | -$307K |
|
1819
Cheniere Energy
CQP
$31.3B
| $577K | ﹤0.01% |
17,460
| – | – |
|
1820
Texas Roadhouse
TXRH
$13.7B
| $577K | ﹤0.01% |
22,200
-41,600
| -65% | -$1.05M |
|
1821
Argan
AGX
$8.37B
| $576K | ﹤0.01% |
15,436
+7,300
| +90% | +$219K |
|
|
FNFG
1822
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $576K | ﹤0.01% |
65,960
-10,100
| -13% | -$89.4K |
|
|
JNS
1823
DELISTED
Janus Capital Group Inc
JNS
| $574K | ﹤0.01% |
+46,000
| New | +$541K |
|
|
DCH
1824
Dauch Corp
DCH
$1.51B
| $573K | ﹤0.01% |
30,332
-32,200
| -51% | -$593K |
|
1825
Pacific Biosciences
PACB
$370M
| $573K | ﹤0.01% |
92,794
| – | – |
|
Similar funds
VGA
AQR Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, AQR Capital Management held 2,714 positions worth $37.1B, up 12% from $33.1B the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
AQR Capital Management's Q2 2014 filing shows 178 new, 1,030 increased, 953 reduced and 205 closed positions. Its largest new stake was AstraZeneca: 1,186,418 shares worth $88.2M. The largest sale was BEAM INC COM STK (DE), an estimated $215M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
- AQR Capital Management's largest Q2 2014 buy was AstraZeneca: 1,186,418 shares worth $88.2M.
- AQR Capital Management added most to EOG Resources in Q2 2014, an estimated $143M increase.
- AQR Capital Management's biggest Q2 2014 reduction was Omnicom Group, cutting an estimated $165M.
- AQR Capital Management fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $215M.
- AQR Capital Management's ten largest holdings make up 8.6% of its $37.1B portfolio in Q2 2014.
- AQR Capital Management opened 178 new positions and closed 205 in Q2 2014.
- AQR Capital Management's portfolio value rose 12% quarter-over-quarter to $37.1B.
Based on AQR Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.